Notably, all patients with genetically altered ACC had ABCA1 amplification, whereas all patients with genetically altered COAD, diffuse large B-cell lymphoma, uterine sarcoma, THYM, KIRP, and KIRC had ABCA1 mutations. Here, ABCA1 is linked to diffuse large B-cell lymphoma.